KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Total Liabilities (2019 - 2026)

GoodRx Holdings' Total Liabilities history spans 7 years, with the latest figure at $787.8 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 18.75% to $787.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $787.8 million, a 18.75% increase, with the full-year FY2025 number at $787.8 million, up 18.75% from a year prior.
  • Total Liabilities hit $787.8 million in Q4 2025 for GoodRx Holdings, up from $724.8 million in the prior quarter.
  • Over the last five years, Total Liabilities for GDRX hit a ceiling of $826.8 million in Q4 2023 and a floor of $640.9 million in Q1 2025.
  • Historically, Total Liabilities has averaged $758.8 million across 5 years, with a median of $775.0 million in 2021.
  • Biggest five-year swings in Total Liabilities: fell 27.92% in 2021 and later increased 18.75% in 2025.
  • Tracing GDRX's Total Liabilities over 5 years: stood at $775.9 million in 2021, then increased by 1.79% to $789.8 million in 2022, then rose by 4.69% to $826.8 million in 2023, then dropped by 19.77% to $663.4 million in 2024, then increased by 18.75% to $787.8 million in 2025.
  • Business Quant data shows Total Liabilities for GDRX at $787.8 million in Q4 2025, $724.8 million in Q3 2025, and $675.7 million in Q2 2025.